Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/20/2003US20030216404 Hydroxamic acid derivatives
11/20/2003US20030216403 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent as well as treats asthma
11/20/2003US20030216401 Anti-obesity 1, 2, 3, 4, 10, 10a-hexahydropyrazino[1, 2-a] indoles
11/20/2003US20030216400 Administering folic acid or a folate and tetrahydrobiopterin (BH4) for reducing superoxide (O2) production and enhancing nitric oxide (NO) synthesis
11/20/2003US20030216399 A dipeptide containing bi or tri-heterocylic ring with nitrogen atom which forms amide with carbonyl group of dipeptide chain; useful for treating osteoporosis, congestive heart failure and accelerates wound healing
11/20/2003US20030216398 Soluble beta amyloid precursor protein secretion promoters
11/20/2003US20030216397 A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent
11/20/2003US20030216395 Imidazo-triazine derivatives as ligands for GABA receptors
11/20/2003US20030216393 Administering to a patient in need an effective pain treating amount of a substituted 1-aminobutan-3-ol compound to treat migraines, hyperalgesia, inflammatory pain, and post-operative pain
11/20/2003US20030216392 Aryl or heteroaryl substituted ethylcarbonylsulfonamide derivatives used as inhibitors of neutrophils chemotaxis and degranulation induced by interleukin 8
11/20/2003US20030216391 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
11/20/2003US20030216390 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
11/20/2003US20030216389 Therapeutic morpholino-substituted compounds
11/20/2003US20030216388 Cyclocarbamate derivatives as progesterone receptor modulators
11/20/2003US20030216387 Benzamide derivatives, particularly esterified cisapride derivatives
11/20/2003US20030216385 Triazole derivatives
11/20/2003US20030216384 Composition and method for treating hypertension
11/20/2003US20030216383 Compounds useful as reversible inhibitors of cysteine proteases
11/20/2003US20030216382 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance
11/20/2003US20030216380 Novel gamma secretase inhibitors
11/20/2003US20030216379 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
11/20/2003US20030216378 Azepino[4,5-b]pyrano[3,2-e]indoles
11/20/2003US20030216377 Vitronectin receptor antagonist
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/20/2003US20030216374 Antibiotic oxazolidinone derivatives
11/20/2003US20030216373 Activity against both Gram-positive and Gram-negative pathogens are generally regarded as having a broad spectrum of activity
11/20/2003US20030216372 Inhibitors of serine and metallo-beta-lactamases
11/20/2003US20030216371 Synthetic catalytic free radical scavengers usefuyl as antioxidants for prevention and therapy of disease
11/20/2003US20030216369 Administering compounds which inhibit heat shock protein 90 proteins; methods block Rb negative or deficient cells in the G2/M phase of the cell cycle and rapidly causes their destruction
11/20/2003US20030216368 Hormone replacement therapy
11/20/2003US20030216367 In perimenopausal, menopausal, and postmenopausal women through the sequential administration of combinations of conjugated estrogens and trimegestone
11/20/2003US20030216366 Step-down estrogen therapy
11/20/2003US20030216365 Use of mometasone furoate for treating airway passage and lung diseases
11/20/2003US20030216364 Dermatological Formulation
11/20/2003US20030216361 Therapeutic compositions effective against gram positive bacteria
11/20/2003US20030216360 Subjecting a supersaturated solution containing a steroid to wet milling while crystallizing, in order to obtain a primary particle suspension.
11/20/2003US20030216359 Administering vitamin D or a derivative and a cytotoxic agent or a glucocorticoid and, optionally, a bisphosphonate
11/20/2003US20030216358 Method for enhancing bone mineral density gain
11/20/2003US20030216357 Compositions for improving lipid content in the blood
11/20/2003US20030216356 Cause the selective destruction of tumour vasculature; are used to inhibit and/or reverse, and/or alleviate symptoms of angiogenesis
11/20/2003US20030216355 Process for preventing protozoal diseases
11/20/2003US20030216354 Prepared from Penicillium sp.; treatment of plasmodia, trypanosomes and carcinosis.
11/20/2003US20030216353 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
11/20/2003US20030216352 Multicomponent complex for use with a substrate
11/20/2003US20030216350 Administering orally a single formulation having 0.3-10 mg vitamin B12 and 0.1-0.4 mg folic acid.
11/20/2003US20030216349 Method for treating arrhythmias
11/20/2003US20030216348 Aminosugar, glycosaminoglycan, and S-Adenosylmethionine composition for the treatment and repair of connective tissue
11/20/2003US20030216347 Genetic material composed of a polynucleotide complexed with an amphipathic compound, a polymer or a nonviral vector is delivered to the parenchymal cell altering its endogenous properties
11/20/2003US20030216344 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
11/20/2003US20030216343 Expression vectors for stimulating an immune response and methods of using the same
11/20/2003US20030216342 Expression vectors for stimulating an immune response and methods of using the same
11/20/2003US20030216340 Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
11/20/2003US20030216335 Treating endometriosis by contacting the subject with a nucleic acid that modulates the expression of VEGF, VEGFR1, and/or VEGFR2
11/20/2003US20030216333 Antisense modulation of glycogen synthase kinase3 alpha expression
11/20/2003US20030216331 Micelles
11/20/2003US20030216330 Especially for methicillin or vancomycin resistant Staphylococcus aureus, vancomycin resistant Enterococci or glycopeptide-intermediate Staphylococcus aureus
11/20/2003US20030216329 Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s)
11/20/2003US20030216328 Androgen derivatives and uses thereof
11/20/2003US20030216326 Compositions comprising lignin and methods of making and using the same
11/20/2003US20030216325 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
11/20/2003US20030216324 Five-member heterocyclic compounds substituted with an alpha-amino carbonyl group; antiasthma agents
11/20/2003US20030216314 Methods of reducing angiogenesis
11/20/2003US20030216305 Identification and characterization of a polypeptide having homology to the sarcoma-amplified protein SAS
11/20/2003US20030216303 Emulsion preconcentrates containing cyclosporin or a macrolide
11/20/2003US20030216297 Pharmaceutical composition
11/20/2003US20030216294 Synergistic effect of a sulfonylurea and/or non-sulfonylurea Kchannel blocker, and a phosphodiesterase 3 type inhibitor
11/20/2003US20030216290 Methods and compositions of treating and/or preventing diabetic retinopathy with pericyte apoptosis inhibitors
11/20/2003US20030216288 Methods and compositions for treating aids and HIV-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules
11/20/2003US20030216287 N-(2-chlorophenyl) hydroxy- or alkoxyalkanamides, e.g.,N-(5-Chloro-2-hydroxyphenyl)-2-(2-hydroxyphenoxy)acetamid e); can deliver a broad range of active agents by various routes.
11/20/2003US20030216285 Selected from the group consisting of alloxazines and photosensitizers
11/20/2003US20030215943 Antisense modulation of apolipoprotein B expression
11/20/2003US20030215918 Comprises nucleotide sequences coding tyrosine kinase receptor binding protein (EFL-1) for treating and diagnosing cell proliferative disorders
11/20/2003US20030215889 Membrane preparation comprising calcium channel transport protein for screening and identifying modulator of ion transport; for prevention and treatment of nervous tissue injuries and diabetes
11/20/2003US20030215885 Using presence of antibody complex to diagnose inflammatory diseases; antiiflammatory agents; immunoassay
11/20/2003US20030215879 Comprise enzymatic polypeptide for use in the treatment of inflammation; aniinflammatory agents
11/20/2003US20030215869 Use of azetidinone compounds
11/20/2003US20030215861 Methods of treating a BRCA associated disorder
11/20/2003US20030215852 Novel pancortin-Pablo protein interactions and methods of use thereof
11/20/2003US20030215840 Identifying compounds capable of treating atherosclerosis, reperfusion injury, hypertension, restenosis, arterial inflammation, heart failure, thrombosis and endothelial cell disorders
11/20/2003US20030215823 Uses of galanin GALR2 receptors
11/20/2003US20030215785 Solution containing platelet activation inhibitors for pathogen reducing and storing blood platelets
11/20/2003US20030215781 Containing alkali ions, electrolytes, a buffer, polyol, saccharide and hydroxamic acid derivatives
11/20/2003US20030215562 Crystal structure, enzyme resistance, nonhydrolyzing, nonabsorption in the small intestine, and passes into the large intestine, fermentation by colonic microflora to maintain colonic health
11/20/2003US20030215561 Crystal structure, enzyme resistance, nonhydrolyzing, nonabsorption in the small intestine, and passes into the large intestine, fermentation by colonic microflora to maintain colonic health
11/20/2003US20030215556 Reduced calorie fat compositions
11/20/2003US20030215534 Mixing psyllium seeds with basic solutions, then seperating the insoluble and soluble gels, disinfecting, and acidifying to form compressible polysaccharides used as dietary fiber
11/20/2003US20030215533 Method of preventing respiratory infections
11/20/2003US20030215532 Cooling or heating sensitizers such as oleoresin or spilanthol, for use in foods, drugs or cosmetics
11/20/2003US20030215528 Prophylaxis and prevention of cancer, tumors, hyperplasia, hypertrophy or dysplasia comprising administering nitrates such as nitroglycerin; angiogenesis inhibitors
11/20/2003US20030215527 Novel substituted benzimidazole dosage forms and method of using same
11/20/2003US20030215526 Stable formulations of angiotensin converting enzyme (ACE) inhibitors
11/20/2003US20030215524 Stable pharmaceutical composition useful for treating gastrointestinal disorders
11/20/2003US20030215522 Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
11/20/2003US20030215519 Preferential plugging of vascular sytems of mammals using microstructure particles comprising hydrolytically degradable crosslinked gels
11/20/2003US20030215518 Immediate release eplerenone compositions
11/20/2003US20030215516 Wet milling saturated solutions containing drugs such as steroids, while crystallizing to obtain microstructure particles in suspension
11/20/2003US20030215514 Dispersible macromolecule compositions and methods for their preparation and use
11/20/2003US20030215512 Stable glassy state powder formulations
11/20/2003US20030215510 A delayed delivery drug dose to a fluid environment consists of a dose of drug, a second formulation with imbibes fluid and expands, a wall that confines both and permeable to the passage of fluid, a subcoat of hydroxyalkyl cellulose
11/20/2003US20030215509 Coated sustained release tablets of a hygroscopic compound for once-a-day therapy
1 ... 5270 5271 5272 5273 5274 5275 5276 5277 5278 5279 5280 5281 5282 5283 5284 5285 5286 5287 5288 5289 5290 ... 7860